BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30724651)

  • 1. Effects of
    Ye H; Sui D; Liu W; Yuan Y; Ouyang Z; Wei Y
    Xenobiotica; 2019 Dec; 49(12):1478-1484. PubMed ID: 30724651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and Characterization of a CYP2C11-Null Rat Model by Using the CRISPR/Cas9 Method.
    Wei Y; Yang L; Zhang X; Sui D; Wang C; Wang K; Shan M; Guo D; Wang H
    Drug Metab Dispos; 2018 May; 46(5):525-531. PubMed ID: 29444903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo evaluation of cucurbitacin E on rat hepatic CYP2C11 expression and activity using LC-MS/MS.
    Lu J; Ding T; Qin X; Liu M; Wang X
    Sci China Life Sci; 2017 Feb; 60(2):215-224. PubMed ID: 26354504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the impact of 16-dehydropregnenolone on the activity and expression of rat hepatic cytochrome P450 enzymes.
    Ramakrishna R; Bhateria M; Singh R; Bhatta RS
    J Steroid Biochem Mol Biol; 2016 Oct; 163():183-92. PubMed ID: 27224941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of recombinant CYP2C11: a vitamin D 25-hydroxylase and 24-hydroxylase.
    Rahmaniyan M; Patrick K; Bell NH
    Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E753-60. PubMed ID: 15585593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of imrecoxib on mRNA and protein expression of CYP2C11 enzyme in rats.
    Wu X; An Q; Dong J; Wang K; Jin Y; Liu X; Zhang Z
    Biomed Chromatogr; 2022 Oct; 36(10):e5439. PubMed ID: 35778888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosuvastatin suppresses the liver microsomal CYP2C11 and CYP2C6 expression in male Wistar rats.
    Zachařová A; Siller M; Spičáková A; Anzenbacherová E; Skottová N; Anzenbacher P; Večeřa R
    Xenobiotica; 2012 Aug; 42(8):731-6. PubMed ID: 22360448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the biotransformation of N-(2-hydroxyphenyl)-2-propylpentanamide (an aryl valproic acid derivative) by CYP2C11, using in silico predictions and in vitro studies.
    Mendieta-Wejebe JE; Silva-Trujillo A; Bello M; Mendoza-Figueroa HL; Galindo-Alvarez NL; Albores A; Tamay-Cach F; Rosales-Hernández MC; Romero-Castro A; Correa-Basurto J
    J Pharm Pharmacol; 2020 Jul; 72(7):938-955. PubMed ID: 32307724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic ethanol on hepatic and renal CYP2C11 in the male rat: interactions with the Janus-kinase 2-signal transducer and activators of transcription proteins 5b pathway.
    Badger TM; Ronis MJ; Frank SJ; Chen Y; He L
    Endocrinology; 2003 Sep; 144(9):3969-76. PubMed ID: 12933671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-dependent expression of CYP2C11 in spleen, thymus and bone marrow regulated by growth hormone.
    Thangavel C; Dhir RN; Volgin DV; Shapiro BH
    Biochem Pharmacol; 2007 Nov; 74(10):1476-84. PubMed ID: 17868651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein restoration in low-birth-weight rat offspring derived from maternal low-protein diet leads to elevated hepatic CYP3A and CYP2C11 activity in adulthood.
    Sohi G; Barry EJ; Velenosi TJ; Urquhart BL; Hardy DB
    Drug Metab Dispos; 2014 Feb; 42(2):221-8. PubMed ID: 24212381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activities of rat cytochrome P450 3A and 2C isoforms are increased in vivo by magnesium sulfate as evidenced by enhanced oxidation of bupivacaine and testosterone in liver microsomes.
    Saito M; Okutomi T; Shimizu M; Matsumoto Y; Yamazaki H; Hoka S
    Drug Metab Pharmacokinet; 2006 Jun; 21(3):201-7. PubMed ID: 16858123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined contributions of impaired hepatic CYP2C11 and intestinal breast cancer resistance protein activities and expression to increased oral glibenclamide exposure in rats with streptozotocin-induced diabetes mellitus.
    Liu H; Liu L; Li J; Mei D; Duan R; Hu N; Guo H; Zhong Z; Liu X
    Drug Metab Dispos; 2012 Jun; 40(6):1104-12. PubMed ID: 22393122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antidepressant drugs on cytochrome P450 2C11 (CYP2C11) in rat liver.
    Wójcikowski J; Haduch A; Daniel WA
    Pharmacol Rep; 2013; 65(5):1247-55. PubMed ID: 24399720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in plasma pharmacokinetics and hepatic metabolism of geissoschizine methyl ether from Uncaria hook in rats.
    Kushida H; Matsumoto T; Ikarashi Y; Nishimura H; Yamamoto M
    J Ethnopharmacol; 2021 Jan; 264():113354. PubMed ID: 32898626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Chronic Renal Failure on Brain Cytochrome P450 in Rats.
    Naud J; Harding J; Lamarche C; Beauchemin S; Leblond FA; Pichette V
    Drug Metab Dispos; 2016 Aug; 44(8):1174-9. PubMed ID: 27271372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of neuroleptics on cytochrome P450 2C11 (CYP2C11) in rat liver.
    Haduch A; Wójcikowski J; Daniel WA
    Pharmacol Rep; 2011; 63(6):1491-9. PubMed ID: 22358097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of in vitro and in vivo treatment with mitomycin C on activities of CYP2D1/2, CYP2C11, and CYP1A2 in rat liver.
    Hao FR; Yan MF; Tong SG; Xu LM; Jn YZ
    Yao Xue Xue Bao; 2004 Nov; 39(11):897-903. PubMed ID: 15696929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of tolbutamide and its metabolite 4-hydroxy tolbutamide in poloxamer 407-induced hyperlipidemic rats.
    Choi MR; Kwon MH; Cho YY; Choi HD; Kim YC; Kang HE
    Biopharm Drug Dispos; 2014 Jul; 35(5):264-74. PubMed ID: 24590592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irreversible perinatal imprinting of adult expression of the principal sex-dependent drug-metabolizing enzyme CYP2C11.
    Das RK; Banerjee S; Shapiro BH
    FASEB J; 2014 Sep; 28(9):4111-22. PubMed ID: 24942648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.